Skip to content

Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.

Luminothérapie Chez Les Patients présentant un état de la Conscience altérée: évaluations Comportementale, de Neuroimagerie et (Neuro)Physiologique.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03174119
Enrollment
50
Registered
2017-06-02
Start date
2019-02-28
Completion date
2021-01-31
Last updated
2018-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness

Brief summary

In this randomized, double-blind, placebo controlled project, the investigators would like to assess the effect of a specific light, as compared to placebo light, on wakefulness (circadian rhythms, homeostasy, sleep-wake cycle), awareness (perceptual and self consciousness), cognition (attention, memory) and underlying brain activity (electrophysiology and neuroimaging)

Detailed description

The investigators will use behavioral (CRS-R, CAP, actimeter, brainstem reflexes), physiological (body core temperature, saliva, urine, heart rate, blood sample), neuroimaging and neurophysiological tools (PET, fMRI, TMS-EEG, resting-state and auditory paradigm EEG) before, during and after treatment.

Interventions

DEVICELight therapy - active

Active light will be used for one week, as compared to placebo light.

Placebo light will be used for one week, as compared to real light exposition.

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* disorder of consciousness * 6 weeks post-injury

Exclusion criteria

* dysautonomia * acute illnesses (infections with fever) * medication that is known to affect circadian rhythmicity (melatonin) * uncorrected sensorial deficits or documented history of significant neurological, neurosurgical, developpemental or psychiatric disorders * previously known cerebral lesions prior to the brain's insult that lead to disorder of consciousness * any contraindication to MRI, EEG, TMS-EEG, or PET (e.g., electronic implanted devices, active epilepsy, external ventricular drain) * not medically stable

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Coma Recovery Scale-Revised scores.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with behavioral analyses and diagnosis through the CRS-R results.

Secondary

MeasureTime frameDescription
Change in sleep-wake cycles through the actimetry, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with behavioral analyses through the arms movements measured with the actimetry.
Change in sleep-wake cycles through the brain metabolism with Positron Emission Tomography, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with PET scan analyses.
Change in sleep-wake cycles through the hemodynamic function of the brain with functional Magnetic Resonance Imaging, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with fMRI analyses.
Change in sleep-wake cycles through the Nociception Coma Scale-Revised, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with behavioral analyses through the NCS-R results.
Change in sleep-wake cycles through analyses of melatonine hormone, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with urine analyses.
Change in sleep-wake cycles through temperature measurements, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with body core temperature analyses.
Change in the outcomes by the assessment of the Glasgow Outcome Scale Extended, after the study.2 years afterImprovement of the recovery's outcomes after the end of the real light therapy exposure.
Change in sleep-wake cycles through the electrical activity of the brain with electroencephalography, after the exposition of real light instead of placebo light.4 weeks studyIdentify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with EEG analyses.

Contacts

Primary ContactSéverine Blandiaux, 1
severine.blandiaux@ulg.ac.be+3243663915
Backup ContactOlivia Gosseries, 1
ogosseries@ulg.ac.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026